[1]
Sharif, K.; Kurnick, A.; Coplan, L.; Alexander, M.; Watad, A.; Amital, H.; Shoenfeld, Y. The Putative Adverse Effects of Bisphenol A on Autoimmune Diseases. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(7), 665-676.
[2]
Lisco, G.; Giagulli, V.A.; Iovino, M.; Guastamacchia, E.; De Pergola, G.; Triggiani, V. Endocrine-Disrupting Chemicals: Introduction to the Theme. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(7), 677-685.
[3]
Schiesaro, M.G.; Amato, A.M.L.; Maneschi, C.; Sciabica, V.; Pigatto, E.; Sanna, M. The Male Reproductive System and Endocrine Disruptors. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(7), 686-703.
[4]
Giannattasio, R.; Lisco, G.; Giagulli, V.A.; Settembrini, S.; De Pergola, G.; Guastamacchia, E.; Lombardi, G.; Triggiani, V. Bone Disruption and Environmental Pollutants. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(7), 704-715.
[5]
Charitos, I.A.; Topi, S.; Gagliano-Candela, R.; De Nitto, E.; Polimeno, L.; Montagnani, M.; Santacroce, L. The Toxic Effects of Endocrine Disrupting Chemicals (EDCs) on Gut Microbiota: Bisphenol A (BPA) A Review. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(7), 716-727.
[6]
Lazurova, Z.; Lazurova, I.; Shoenfeld, Y. Bisphenol A as a Factor in the Mosaic of Autoimmunity. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(7), 728-737.